![Mary Sheahan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mary Sheahan
Direktor/Vorstandsmitglied bei CENTOGENE N.V.
Aktive Positionen von Mary Sheahan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CENTOGENE N.V. | Direktor/Vorstandsmitglied | 01.12.2022 | - |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Finanzdirektor/CFO | - | - |
Karriereverlauf von Mary Sheahan
Statistik
International
Deutschland | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CENTOGENE N.V. | Commercial Services |
Private Unternehmen | 1 |
---|---|
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Mary Sheahan
- Erfahrung